Plasma neurofilament light chain: A biomarker for neuronal injury in Alzheimer's disease and the imperative for sex-specific interpretation
Brain Medicine · 30.06.2026 · 1-8
DOI: 10.61373/bm026y.0051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Medicine, erschienen am 30.06.2026. Verfasst von Yingfeng Xia und 3 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder in which early and objective detection of neuronal injury is crucial. Plasma neurofilament light chain (NfL), a cytoskeletal protein released upon axonal damage, has emerged as a leading candidate for a noninvasive, blood-based biomarker. This mini-review summarizes recent evidence and highlights that elevated plasma NfL levels correlate strongly with cognitive decline, brain atrophy, and disease progression in AD. Recent studies highlight the recognition of significant sex differences: for the same increase in plasma NfL, men exhibit more severe cognitive impairment and neuropathological burden than women. This underscores the necessity for sex-specific interpretation of plasma NfL levels to enhance its diagnostic, prognostic, and therapeutic monitoring utility in AD.
Zitieren
APA
Xia, Y., Yuan, P., Fei, G., & Cheng, X. (2026). Plasma neurofilament light chain: A biomarker for neuronal injury in Alzheimer's disease and the imperative for sex-specific interpretation. Brain Medicine, 1-8. https://doi.org/10.61373/bm026y.0051
Vancouver
Xia Y, Yuan P, Fei G, Cheng X. Plasma neurofilament light chain: A biomarker for neuronal injury in Alzheimer's disease and the imperative for sex-specific interpretation. Brain Medicine. 2026:1-8. doi:10.61373/bm026y.0051
BibTeX
@article{Xia2026,
author = {Xia, Yingfeng and Yuan, Peng and Fei, Guoqiang and Cheng, Xiaoqin},
title = {Plasma neurofilament light chain: A biomarker for neuronal injury in Alzheimer's disease and the imperative for sex-specific interpretation},
journal = {Brain Medicine},
year = {2026},
pages = {1--8},
doi = {10.61373/bm026y.0051}
}
EUVIMED